Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total liabilities by Year
Crinetics Pharmaceuticals — Total liabilities ($M) ($M)
Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total liabilities: $134M in FY2025, up 22.2% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
Source: SEC Filing ↗
Reported in SEC XBRL (CIK 0001699813 Crinetics Pharmaceuticals).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Crinetics Pharmaceuticals — Total liabilities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 134 | +22.2% | SEC Filing ↗ |
| FY2024 | Dec 31, 2024 | 110 | +14.1% | SEC Filing ↗ |
| FY2023 | Dec 31, 2023 | 96.3 | +168.5% | SEC Filing ↗ |
| FY2022 | Dec 31, 2022 | 35.9 | +88.0% | SEC Filing ↗ |
| FY2021 | Dec 31, 2021 | 19.1 | +31.2% | SEC Filing ↗ |
| FY2020 | Dec 31, 2020 | 14.5 | +9.7% | SEC Filing ↗ |
| FY2019 | Dec 31, 2019 | 13.2 | +18.3% | SEC Filing ↗ |
| FY2018 | Dec 31, 2018 | 11.2 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total liabilities ($M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/crinetics-liabilities
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.